Linked Life Data

18818049

Source:http://linkedlifedata.com/resource/pubmed/id/18818049

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-11-3
pubmed:abstractText
In general, pregnancies in women with inflammatory myopathy (IM) in sustained remission have a favourable outcome, whereas those pregnant patients with active IM have an increased risk for foetal loss, intra-uterine growth retardation and/or prematurity. The effect of pregnancy on disease activity is variable. All patients with active IM need to be followed by a multidisciplinary team including obstetricians, rheumatologists and/or internists in close relationship with a neonatal intensive care unit. Maternal disease should be treated with corticosteroids, using the same dosage and regimen as for non-pregnant women and according to the disease activity and severity.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0755-4982
pubmed:author
pubmed:issnType
Print
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1652-6
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Pregnancy and inflammatory myopathies].
pubmed:affiliation
Service d'Histologie, Centre de Référence des Maladies Neuromusculaires, Garches-Necker-Mondor-Hendaye, INSERM U841, CHU Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France. dalia.dimitri@hmn.aphp.fr
pubmed:publicationType
Journal Article, English Abstract, Review